Vildagliptin

4 trials 2 recruiting AGastroenterology

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

2 Completed trials

4 Sponsors

7 Countries

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 1 Phase IV: 2

Indications tested

Type 2 diabetes mellitus 1

Sponsors using this IMP

Centre Hospitalier Universitaire Rouen 1 Eli Lilly & Co. 1 Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA 1 Medica Scientia Innovation Research S.L. 1

All trials

4 total

A Study of Tirzepatide Compared with Intensified Conventional Care in Adult Participants with Type 2 Diabetes (SURPASS-EARLY) Recruiting

2022-501073-40-00 Phase IV 5 countries Eli Lilly & Co.
PRODIG : Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early post-transplant perio… Recruiting

2024-516272-14-00 Phase III 1 country Centre Hospitalier Regional Universitaire
Clinical trial to evaluate whether personalized treatment based on genetics improves type 2 diabetes control Ended

2025-520686-46-00 Phase IV 1 country Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospita…
Study to evaluate the effect of metformin in the prevention of hyperglycemia in HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients… Ended

2024-511295-33-00 Phase II 1 country Medica Scientia Innovation Research S.L.

Showing 1–4 of 4 trials

← All drugs A–Z